E-Selectin-Overexpressing Mesenchymal Stem Cell Therapy Confers Improved Reperfusion, Repair, and Regeneration in a Murine Critical Limb Ischemia Model

AIMS: Novel cell-based therapeutic angiogenic treatments for patients with critical limb ischemia may afford limb salvage. Mesenchymal stem cells (MSCs) do not overexpress E-selectin; however, we have previously demonstrated the cell-adhesion molecule's vital role in angiogenesis and wound heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiroz, Hallie J., Valencia, Samantha F., Shao, Hongwei, Li, Yan, Ortiz, Yulexi Y., Parikh, Punam P., Lassance-Soares, Roberta M., Vazquez-Padron, Roberto I., Liu, Zhao-Jun, Velazquez, Omaida C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841646/
https://www.ncbi.nlm.nih.gov/pubmed/35174227
http://dx.doi.org/10.3389/fcvm.2021.826687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841646/
https://www.ncbi.nlm.nih.gov/pubmed/35174227
http://dx.doi.org/10.3389/fcvm.2021.826687

Ejemplares similares